49 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
INVESTOR CONTACT:
Tim McCarthy
LifeSci Advisors
tim@lifesciadvisors.com
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
Exhibit Index
Exhibit
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
INVESTOR CONTACT:
Tim McCarthy
LifeSci
6-K
EX-99.2
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation
6-K
cf123hu
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
EX-99.1
ckmw6a
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
EX-99.1
s78iz 265qb
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
dyckxhy3
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
mhpqznu9 i2s5pva1
5 Jun 23
Current report (foreign)
4:28pm
6-K
wizn2pl eq0rr
1 Jun 23
Current report (foreign)
4:24pm
6-K
EX-99.1
6409xwhbgnh
1 Jun 23
Current report (foreign)
4:24pm
6-K
EX-99.1
5utlohgopcyqi
11 Apr 23
Connect Biopharma Reports Full Year 2022 Financial Results
5:00pm
6-K
0k22jota vb2uisfa
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
6-K
EX-99.1
0m1r7 t2a
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
6-K
c43q9bcf3
4 Oct 22
Current report (foreign)
7:16am
6-K
1tqidq h3
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
6-K
EX-99.1
lvahiu 8p
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
6-K
jd48s094zhp coq9dth4
11 Jul 22
Current report (foreign)
4:30pm